AmerisourceBergen Acquires Xcenda

AmerisourceBergen, a prominent player in pharmaceutical services and distribution, acquired Xcenda, a healthcare consulting firm specializing in market access and health economics. This acquisition allowed AmerisourceBergen to enhance its capabilities in providing comprehensive solutions to pharmaceutical manufacturers and healthcare providers. Xcenda's expertise in health economics and outcomes research complemented AmerisourceBergen's existing services, enabling the company to offer more robust support to clients navigating the complexities of the healthcare landscape. Following the acquisition, Mauch transitioned from being the founder of Xcenda to a senior leadership role within AmerisourceBergen, reflecting the integration of Xcenda's operations into the larger corporate structure. This strategic move not only expanded AmerisourceBergen's service offerings but also positioned the company to better address the evolving needs of the healthcare market, particularly in areas related to drug pricing, reimbursement, and patient access.